Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 9/2000

01-11-2000

Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States)

Authors: Patricia F. Coogan, Lynn Rosenberg, Julie R. Palmer, Brian L. Strom, Paul D. Stolley, Ann G. Zauber, Samuel Shapiro

Published in: Cancer Causes & Control | Issue 9/2000

Login to get access
Metadata
Title
Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States)
Authors
Patricia F. Coogan
Lynn Rosenberg
Julie R. Palmer
Brian L. Strom
Paul D. Stolley
Ann G. Zauber
Samuel Shapiro
Publication date
01-11-2000
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 9/2000
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1008982417022

Other articles of this Issue 9/2000

Cancer Causes & Control 9/2000 Go to the issue

OriginalPaper

Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)

OriginalPaper

Menstrual and reproductive factors and risk of gastric cancer: a Norwegian cohort study

OriginalPaper

A record-based evaluation of induced abortion and breast cancer risk (United States)

OriginalPaper

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

OriginalPaper

Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries)

OriginalPaper

Physical activity and postmenopausal endometrial cancer risk (Sweden)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits